286 THE NOVEL FC-ENGINEERED CD33 ANTIBODY BI 836858 IMPROVES HEMATOPOIESIS BY PROTECTING HSC/HPC FROM ROS-MEDIATED DNA DAMAGE IN MDS. Issue 1 (April 2015) - Eksioglu, E.A.